Inmunorreactividad contra los editopos Gal (alfa 1-2) Gal y Gal (alfa 1-3)Gal en suero de pacientes con cáncer

Tremont Lukats, Ivo; Arbona Haddad, Esther; Avila, José Luis; Hernández Morales, Dimas; Rojas, Miguel; Martínez, Alejandro.
Rev. venez. oncol ; 7(1): 12-23, ene.-abr. 1995. ilus
Artículo en Español | LILACS | ID: lil-180836

Documentos relacionados

  1. Accelerating the understanding of cancer biology through the lens of genomics.
  2. Macrophages at the interface of the co-evolving cancer ecosystem.
  3. Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment.
  4. Embracing cancer complexity: Hallmarks of systemic disease.
  5. From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment.
  6. Pan-cancer proteogenomics characterization of tumor immunity.
  7. Coordinated cancer chaos.
  8. Only the beginning: 50 years of progress toward curing childhood cancer.
  9. Mapping the long road to cancer.
  10. Cancer neuroscience: State of the field, emerging directions.